The search for safer, more sustainable sun protection ingredients has taken a significant step forward. Scientists in Japan have identified a key enzyme that unlocks the biosynthetic pathway behind saclipins, a pair of unusual ultraviolet-absorbing compounds produced by an edible freshwater cyanobacterium. The discovery, published in the Journal of Natural Products, offers the first clear biochemical entry point into a pathway that has long resisted explanation, and it demonstrates for the first time that these coveted molecules can be assembled outside the organism through a combination of enzymatic and chemical steps.
Saclipins A and B are oxylipins, a broad family of oxidized fatty acid derivatives that includes many signaling molecules in plants and algae. What makes the saclipins remarkable is their function: they absorb ultraviolet light, and they do so with notable photo- and thermochemical stability. They are produced by Aphanothece sacrum, a cyanobacterium known in Japan as Suizenji-nori, which is traditionally harvested and eaten. Beyond their UV-shielding behavior, saclipins have been reported to show antioxidative and antiglycative activities, making them attractive candidates for cosmetics and functional materials. Yet a stubborn obstacle has kept them out of widespread use: the compounds accumulate only in small amounts in the organism, and the biosynthetic route that creates them was essentially unknown.
That obstacle is precisely what the research team, led by Professor Hakuto Kageyama together with graduate student Yoshie Uchida of the Graduate School of Environmental and Human Sciences at Meijo University, set out to dismantle. Their strategy began with a genome search. Scanning the A. sacrum genome for genes encoding lipoxygenases, a class of enzymes known to oxygenate polyunsaturated fatty acids, the researchers identified two candidates, which they named AsLOX1 and AsLOX2. Lipoxygenases are attractive targets in such searches because they perform regioselective and stereoselective oxygen insertions, the kind of chemistry that natural product pathways often exploit to build structurally complex oxylipins from simple fatty acid precursors.
To test what the two candidate enzymes could actually do, the team produced recombinant versions of both proteins and challenged them with three fatty acid substrates: α-linolenic acid, linoleic acid, and arachidonic acid. The results were decisive. AsLOX2 showed clear activity toward all three substrates, with the strongest activity directed at α-linolenic acid, while AsLOX1 showed no detectable activity under the conditions tested. The contrast between the two enzymes suggested that AsLOX2, not AsLOX1, was the functional player in saclipin biosynthesis, a hypothesis that subsequent experiments would confirm in striking detail.
The key finding came when the researchers examined exactly how AsLOX2 acts on α-linolenic acid. Rather than introducing oxygen at a single position, as many lipoxygenases do, AsLOX2 oxygenates the fatty acid at two distinct positions, producing a doubly oxygenated hydroperoxide known as 9,16-diHPOTE. This molecule is a key intermediate linked to saclipin formation. The team confirmed its identity using chromatographic and mass spectrometric analyses, the standard analytical toolkit for pinning down the structures of unstable oxylipin intermediates. Under optimized conditions, the enzyme converted more than 80 percent of the starting fatty acid into 9,16-diHPOTE within just a few minutes, a level of efficiency that underscores how powerfully catalytic this gateway step is.
“Identifying AsLOX2 as the gateway enzyme gives us an important biochemical entry point for understanding how this unusual UV-absorbing compound is produced,” says Prof. Kageyama. The phrase gateway enzyme is apt: in natural product biosynthesis, the first committed step often determines which branch of metabolism a precursor enters, and knowing which enzyme performs it provides both a mechanistic anchor and a practical handle for reconstruction. With AsLOX2 in hand, the researchers could now attempt something that had not been done before: building saclipins from a fatty acid starting material using a defined enzymatic step followed by chemical transformations.
That is exactly what they did. Starting from the AsLOX2-derived 9,16-diHPOTE, the team first reduced the hydroperoxide to form 9,16-diHOTE, a chemically more stable dihydroxy intermediate. They then applied a chemical oxidation step to generate compounds corresponding to saclipins A and B, confirming the identities of the products by comparison with authentic reference compounds. The reaction produced saclipin A in greater amounts than saclipin B, with the two products appearing at an approximate ratio of 9:1. Although the overall yield was modest, the demonstration was conceptually important: an enzymatic oxygenation step and downstream chemical conversion could be chained together to deliver the finished UV-absorbing molecules.
“The combination of an enzymatic gateway step and chemical conversion demonstrates a practical route toward saclipin production, while also highlighting the downstream reactions that remain to be discovered in the natural pathway,” says Prof. Kageyama. This point captures the dual significance of the work. On one level, it provides a workable semi-synthetic route: a fatty acid can be fed through a highly efficient enzyme and then converted chemically into saclipins, bypassing the need to extract scarce material from cyanobacterial biomass. On another level, it maps the frontier of the unknown. The natural pathway presumably uses enzymes to carry out the reduction and oxidation steps that the researchers performed chemically, and identifying those downstream enzymes remains an open challenge.
The broader implications extend in several directions. First, the study establishes that a single lipoxygenase performs a dual oxygenation that links α-linolenic acid, an abundant and inexpensive plant-derived fatty acid, to the saclipin pathway. That makes alternative production systems, whether purely enzymatic, microbial, or hybrid approaches, a realistic prospect. Engineered microbes supplied with ALA and equipped with AsLOX2 could in principle serve as production platforms, reducing reliance on extraction from A. sacrum and relieving pressure on wild populations of the edible cyanobacterium. Second, the work illuminates how lipid metabolism contributes to stress adaptation. Saclipin accumulation in A. sacrum is strongly stimulated by desiccation stress, and understanding the pathway may clarify how this organism converts membrane fatty acids into protective metabolites when water becomes scarce, a strategy of considerable interest for understanding cyanobacterial resilience.
The authors are careful to note that practical applications remain some distance away. Further work is needed to identify the natural downstream enzymes, and the productivity, safety, stability, and other properties of any production process must be assessed before saclipins can be considered for cosmetic or functional material use. Even so, the trajectory is clear. A molecule once available only in trace quantities from a specialized organism now has a defined biosynthetic entry point, a demonstrated semi-synthetic route, and a growing research program aimed at completing the pathway. For a field searching for natural, stable, UV-absorbing ingredients, the humble Suizenji-nori cyanobacterium and its gateway enzyme may prove to be an unexpectedly rich source of answers.
Subject of Research: Biosynthesis of UV-absorbing saclipin oxylipins in the cyanobacterium Aphanothece sacrum via the lipoxygenase AsLOX2
Article Title: Enzyme discovery opens a new route to natural UV-absorbing saclipins
Article References: Enzyme discovery opens a new route to natural UV-absorbing saclipins. (n.d.). Original publication
Image Credits: AI Generated
DOI: Not provided
Keywords: saclipins, lipoxygenase, AsLOX2, Aphanothece sacrum, cyanobacteria, alpha-linolenic acid, oxylipins, UV-absorbing compounds, biosynthesis, cosmetics, desiccation stress, natural products
Cite Scienmag News
Drew Townsend. (October 14, 2026). Gateway Enzyme Found for Natural UV-Shielding Saclipins. Scienmag. https://scienmag.com/gateway-enzyme-found-for-natural-uv-shielding-saclipins/
Drew Townsend. "Gateway Enzyme Found for Natural UV-Shielding Saclipins." Scienmag, 14 October 2026, https://scienmag.com/gateway-enzyme-found-for-natural-uv-shielding-saclipins/. Accessed 14 October 2026.
Drew Townsend. "Gateway Enzyme Found for Natural UV-Shielding Saclipins." Scienmag. October 14, 2026. https://scienmag.com/gateway-enzyme-found-for-natural-uv-shielding-saclipins/

